NEW YORK (GenomeWeb News) – PGXL Technologies today said that it has been awarded a $300,000 contract from the National Cancer Institute to advance research directed at circulating tumor cells for the early detection of cancer.
Silicon Biosystems believes that its recent acquisition by the Menarini Group, an Italian pharmaceutical company, will provide it with the support to move its cell array platform into the clinical market.
NEW YORK (GenomeWeb News) – Transgenomic said in a document filed with the US Securities and Exchange Commission this week that its shareholders have approved an increase in the number of authorized shares of the firm's common stock from 100 million to 150 million.
This story was originally posted on Dec. 1
Baylor College of Medicine will use Silicon Biosystems' DEPArray platform in research programs related to prenatal diagnostics and molecular oncology, the firm said last week.